Anavex Life Sciences Corp (AVXL)

[tredenwater2]

“ Blarcamesine is safer and once it is approved I expect patients and physicians will start discovering that there are some positive "side effects" that go beyond the targeted disease.”

Hell yes! Who wants to risk death while paying up for, 1 of 12 (?) invasive infusions? Word will spread fast imo. The lid will have to come off one day soon and the drug will sprrad like wildfire as soon as Medicare, Medicaid, and the major medical insurance coverage is approved. Getting the Fda or EMA to approve is only half of the battle. Hopefully they will see the long term benefits, like you mentioned, to further pave the way for prophylactic use.